Apimeds Pharmaceuticals US, Inc. (APUS) short interest & short volume · 3.6% of float short
Apimeds Pharmaceuticals US, Inc. official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
APUS short interest fell 8.2% to 73K shares in the Oct 15, 2026 report (3.6% of float, 1.0 days to cover). Daily short volume averaged 52.3% of volume over the last 20 sessions, up from 42.0% the 20 sessions before, the 100th percentile of its own 20-day averages since Sep 16, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 73K
- prior 80K
- % of float
- 3.6%
- float 2.0M
- Days to cover
- 1.0
- avg vol 9.7M
- Change vs prior report
- -8.2%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 51.3%
- 12K of 23K
- 20-day average
- 52.3%
- prior 42.0%
- Percentile vs own history
- 100th
- 215 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: -32.3%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
APUS's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · APUS overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 11,796 | 22,992 | 51.3% |
| 2026-10-30 | 5,945 | 9,359 | 63.5% |
| 2026-10-29 | 16,214 | 22,164 | 73.2% |
| 2026-10-28 | 9,794 | 35,635 | 27.5% |
| 2026-10-27 | 29,022 | 37,767 | 76.8% |
| 2026-10-26 | 10,312 | 15,796 | 65.3% |
| 2026-10-23 | 13,570 | 23,531 | 57.7% |
| 2026-10-22 | 10,043 | 21,776 | 46.1% |
| 2026-10-21 | 24,639 | 48,576 | 50.7% |
| 2026-10-20 | 15,580 | 37,432 | 41.6% |
Healthcare peers with similar quant ratings
APUS among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- QTTB short interest5.00 · Strong Buy · stock
- AVAH short interest4.99 · Strong Buy · stock
- CDNA short interest4.98 · Strong Buy · stock
- HALO short interest4.97 · Strong Buy · stock
- OSCR short interest4.97 · Strong Buy · stock
- BTSG short interest4.96 · Strong Buy
- REGN short interest4.95 · Strong Buy · stock
- CON short interest4.94 · Strong Buy · stock
APUS short interest FAQ
What is APUS's short interest?
Apimeds Pharmaceuticals US, Inc. (APUS) had 73K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 3.6% of its 2.0M-share float.
How many days to cover does APUS have?
1.0 days: 73K shares short divided by an average daily volume of 9.7M for the Oct 15, 2026 period.
Is APUS short interest rising or falling?
APUS short interest fell (-8.2%) from 80K to 73K shares in the Oct 15, 2026 report.
Is APUS a short squeeze candidate?
Lician's squeeze watch scores APUS 7 out of 100 (low) from the Oct 15, 2026 report: short interest % of float 4.8/40, days to cover 2.5/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of APUS daily volume is sold short?
52.3% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 100th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was APUS's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Apimeds Pharmaceuticals US, Inc. (APUS) was 11,796 shares, 51.3% of 22,992 total volume.
How many APUS short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Apimeds Pharmaceuticals US, Inc. (APUS), from Oct 20, 2026 through Nov 2, 2026.
How did APUS short volume percent change from the prior cached session?
Cached FINRA short volume for Apimeds Pharmaceuticals US, Inc. (APUS) moved from 63.5% on Oct 30, 2026 to 51.3% on Nov 2, 2026, down 12.2 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.